Written Question·Department of Health and Social Care·UIN 99358
Glioblastoma: Medical Treatments
Tabled: 11 December 2025
Answered: 18 December 2025
Question
Lewis Cocking
Conservative — Broxbourne
To ask the Secretary of State for Health and Social Care, what discussions he has had with the MHRA on the potential impact of regulatory reform on the time taken to develop glioblastoma treatments.
Answer
Dr Zubir AhmedThe Medicines and Healthcare Products Regulatory Agency (MHRA) is an executive agency of the Department and regulates medicine, medical devices, and blood components for transfusion in the United Kingdom, with responsibility for ensuring medicines meet ap...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 99358) →